We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+38.8%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$3.79B
AUM Growth
+$1.43B
Cap. Flow
+$661M
Cap. Flow %
17.45%
Top 10 Hldgs %
59.79%
Holding
60
New
6
Increased
1
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
DM
Desktop Metal, Inc.
DM
+$376M
2
EAR
Eargo, Inc. Common Stock
EAR
+$275M
3
OPEN icon
Opendoor
OPEN
+$144M
4
PANW icon
Palo Alto Networks
PANW
+$75.3M
5
UPST icon
Upstart Holdings
UPST
+$23.5M

Top Sells

Rank Stock Value
1
SPT icon
Sprout Social
SPT
+$119M
2
MRSN
Mersana Therapeutics
MRSN
+$111M
3
ALLK
Allakos
ALLK
+$10.8M
4
DKNG icon
DraftKings
DKNG
+$1.41M
5
SENS icon
Senseonics Holdings Inc
SENS
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 65.98%
2 Industrials 13.91%
3 Technology 12.25%
4 Real Estate 4%
5 Consumer Discretionary 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFMD
26
DELISTED
Affimed
AFMD
$35.7M 0.94%
612,649
– –
CBIO
27
Crescent Biopharma
CBIO
$626M
$34.2M 0.9%
90,890
– –
GNCA
28
DELISTED
Genocea Biosciences, Inc.
GNCA
$25.1M 0.66%
10,376,936
– –
MTCR
29
DELISTED
Metacrine, Inc. Common Stock
MTCR
$24.1M 0.64%
3,062,977
– –
UPST icon
30
Upstart Holdings
UPST
$3.03B
$23.4M 0.62%
+573,184
New +$23.5M
CTIC
31
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$23M 0.61%
7,140,450
– –
AVEO
32
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$22.8M 0.6%
3,952,958
– –
LITS
33
Lite Strategy Inc
LITS
$30.9M
$22.5M 0.59%
426,654
– –
PHAS
34
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$22.3M 0.59%
6,643,704
– –
GERN icon
35
Geron
GERN
$949M
$21.4M 0.57%
13,461,538
– –
LUMO
36
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$18.8M 0.5%
526,663
– –
CSBR icon
37
Champions Oncology
CSBR
$72.1M
$18.5M 0.49%
1,713,720
– –
VTGN icon
38
VistaGen Therapeutics
VTGN
$12.8M
$18.2M 0.48%
+312,000
New +$7.96M
XENE icon
39
Xenon Pharmaceuticals
XENE
$6.12B
$15.3M 0.4%
992,107
– –
IVA
40
Inventiva
IVA
$1.13B
$15.1M 0.4%
1,041,666
– –
DZSI
41
DELISTED
DZS Inc. Common Stock
DZSI
$14.8M 0.39%
956,255
– –
TRVI icon
42
Trevi Therapeutics
TRVI
$2.63B
$14.4M 0.38%
5,940,796
– –
SBBP
43
DELISTED
Strongbridge Biopharma plc.
SBBP
$10.1M 0.27%
4,141,308
– –
SENS icon
44
Senseonics Holdings Inc
SENS
$366M
$9.97M 0.26%
573,212
-134,448
-19% -$1.17M
OBSV
45
DELISTED
ObsEva SA Ordinary Shares
OBSV
$9.54M 0.25%
4,586,563
– –
SYBX
46
DELISTED
Synlogic
SYBX
$9.13M 0.24%
281,961
– –
RGLS
47
DELISTED
Regulus Therapeutics
RGLS
$8.71M 0.23%
645,106
+439,860
+214% +$3.23M
TRVN
48
DELISTED
Trevena, Inc.
TRVN
$8.16M 0.22%
6,099
– –
LXRX icon
49
Lexicon Pharmaceuticals
LXRX
$1.1B
$8.15M 0.22%
2,382,286
– –
LQDA icon
50
Liquidia Corp
LQDA
$8.02B
$7.33M 0.19%
2,486,062
– –
1
2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
SFI
Siemens Fonds Invest Munich, Germany $1.75B AUM 26.24% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

NEA Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, NEA Management Company held 60 positions worth $3.79B, up 60% from $2.36B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

NEA Management Company deployed $661M of net new capital in Q4 2020, opening 6 new positions and adding to 1 existing holding. Its largest new stake was Desktop Metal, Inc.: 2,841,609 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 84% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Sprout Social, an estimated $119M trimmed.

  • NEA Management Company's largest Q4 2020 buy was Desktop Metal, Inc.: 2,841,609 shares worth $489M.
  • NEA Management Company added most to Regulus Therapeutics in Q4 2020, an estimated $3.23M increase.
  • NEA Management Company's biggest Q4 2020 reduction was Sprout Social, cutting an estimated $119M.
  • NEA Management Company fully exited Mersana Therapeutics in Q4 2020, selling an estimated $111M.
  • NEA Management Company's ten largest holdings make up 60% of its $3.79B portfolio in Q4 2020.
  • NEA Management Company opened 6 new positions and closed 3 in Q4 2020.
  • NEA Management Company's portfolio value rose 60% quarter-over-quarter to $3.79B.

Based on NEA Management Company's 13F filing for Q4 2020, filed 16 Feb 2021.